scispace - formally typeset
B

B. Mark Evers

Researcher at University of Kentucky

Publications -  385
Citations -  19859

B. Mark Evers is an academic researcher from University of Kentucky. The author has contributed to research in topics: PI3K/AKT/mTOR pathway & Protein kinase B. The author has an hindex of 74, co-authored 356 publications receiving 17623 citations. Previous affiliations of B. Mark Evers include University of Louisville & Markey Cancer Center.

Papers
More filters
Journal ArticleDOI

Stabilization of Snail by NF-κB Is Required for Inflammation-Induced Cell Migration and Invasion

TL;DR: It is found that Snail is stabilized by the inflammatory cytokine TNFalpha through the activation of the NF-kappaB pathway, which is required for the induction of COP9 signalosome 2 (CSN2), which blocks the ubiquitination and degradation of Snail.
Journal ArticleDOI

mTORC1 and mTORC2 regulate EMT, motility and metastasis of colorectal cancer via RhoA and Rac1 signaling pathways

TL;DR: It is found that increased expression of mTOR, Raptor, and Rictor mRNA was noted with advanced stages of CRC, suggesting that mTOR signaling may be associated with CRC progression and metastasis, and provides the rationale for including mTOR kinase inhibitors, which inhibit both mTORC1 and m TORC2, as part of the therapeutic regimen for CRC patients.
Journal ArticleDOI

G9a interacts with Snail and is critical for Snail-mediated E-cadherin repression in human breast cancer

TL;DR: Methylation of histone H3 on lysine 9 (H3K9me2) is critical for promoter DNA methylation of E-cadherin in three TGF-β-induced EMT model cell lines, as well as in CLBC cell Lines, revealing a critical mechanism underlying the epigenetic regulation of EMT.
Journal ArticleDOI

FOXO proteins regulate tumor necrosis factor-related apoptosis inducing ligand expression. Implications for PTEN mutation in prostate cancer.

TL;DR: It is suggested that the decreased activity of FKHRL1 and FKHR in prostate cancers resulting from loss of PTEN leads to a decrease in TRAIL expression that may contribute to increased survival of the tumor cells.